AMAG Austria Metall AG (FRA:AM8)
Germany · Delayed Price · Currency is EUR 24.00
-0.10 (-0.41%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 33.21 | 43.2 | 66.39 | 109.28 | 65.28 | 11.03 | Upgrade |
Depreciation & Amortization | 99.37 | 102.06 | 85.99 | 87.46 | 84.4 | 83.45 | Upgrade |
Loss (Gain) From Sale of Assets | -0.02 | -0.08 | 0.53 | 0.33 | 0.72 | -0.09 | Upgrade |
Loss (Gain) on Equity Investments | -0.05 | -0.12 | -0.14 | -0.16 | -0.12 | -0.12 | Upgrade |
Other Operating Activities | -1.81 | 4.05 | 1.24 | -3.71 | 19.94 | -5.57 | Upgrade |
Change in Accounts Receivable | -39.16 | -38.57 | 12.95 | -13.19 | -40.89 | 11.5 | Upgrade |
Change in Inventory | 43.6 | -17.28 | 51.68 | -88.23 | -132.47 | 1.67 | Upgrade |
Change in Accounts Payable | 23.46 | -1.46 | -17.08 | -5.39 | 43.44 | -11.79 | Upgrade |
Change in Other Net Operating Assets | -39.03 | 27.17 | -20.66 | -0.31 | 5.3 | 17.2 | Upgrade |
Operating Cash Flow | 119.57 | 118.98 | 180.9 | 86.07 | 45.59 | 107.29 | Upgrade |
Operating Cash Flow Growth | -36.58% | -34.23% | 110.17% | 88.79% | -57.50% | -23.34% | Upgrade |
Capital Expenditures | -67.7 | -89.05 | -96.92 | -78.42 | -72.99 | -58.22 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 0.76 | - | Upgrade |
Cash Acquisitions | - | - | - | - | - | -1.33 | Upgrade |
Other Investing Activities | 1.83 | 1.89 | 3.14 | 3.48 | 2.47 | -2.61 | Upgrade |
Investing Cash Flow | -65.87 | -87.16 | -93.78 | -74.95 | -69.77 | -62.17 | Upgrade |
Long-Term Debt Issued | - | 237.5 | 4.15 | 412.54 | 83.36 | 126.67 | Upgrade |
Long-Term Debt Repaid | - | -112.31 | -151.84 | -254.07 | -184.77 | -108.44 | Upgrade |
Net Debt Issued (Repaid) | 49.79 | 125.19 | -147.68 | 158.47 | -101.41 | 18.23 | Upgrade |
Common Dividends Paid | -42.32 | -52.9 | -52.9 | -52.9 | -17.63 | -17.63 | Upgrade |
Other Financing Activities | - | - | -0 | - | - | - | Upgrade |
Financing Cash Flow | 7.47 | 72.29 | -200.58 | 105.57 | -119.04 | 0.6 | Upgrade |
Foreign Exchange Rate Adjustments | -7.84 | 5.74 | -3.27 | 6.98 | 9.75 | -8.15 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -9.44 | - | -0 | Upgrade |
Net Cash Flow | 53.33 | 109.85 | -116.74 | 114.24 | -133.47 | 37.58 | Upgrade |
Free Cash Flow | 51.87 | 29.93 | 83.97 | 7.65 | -27.4 | 49.06 | Upgrade |
Free Cash Flow Growth | -44.65% | -64.36% | 997.56% | - | - | -19.01% | Upgrade |
Free Cash Flow Margin | 3.40% | 2.07% | 5.75% | 0.44% | -2.17% | 5.43% | Upgrade |
Free Cash Flow Per Share | 1.47 | 0.85 | 2.38 | 0.22 | -0.78 | 1.39 | Upgrade |
Cash Interest Paid | 20.93 | 19.05 | 17.67 | 8.96 | 7.45 | 7.87 | Upgrade |
Cash Income Tax Paid | 19.24 | 20.28 | 26.05 | 46.6 | 11.53 | 13.4 | Upgrade |
Levered Free Cash Flow | 8.57 | 2.25 | 49.7 | -39.24 | 0.44 | 19.03 | Upgrade |
Unlevered Free Cash Flow | 22.16 | 15.64 | 63.15 | -30.85 | 7.07 | 25.76 | Upgrade |
Change in Net Working Capital | 37.72 | 34.51 | -16.57 | 128.22 | 62.51 | 10.22 | Upgrade |
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.